Delivery Order SPE2DP26D0001-SPE2DP26F4183
Award Date 4/7/26
Potential Completion Date 1/7/27
Potential Value $36M
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
St. Louis, MO 63146, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Office of the Assistant Secretary for Administration awarded a $418,637.55 firm-fixed-price purchase order to Meridian Medical Technologies, LLC for DuoDote auto-injectors (FPAE NDC #11704-0620-01) with an ultimate completion date of January 5, 2026. The contract was designated as a Total Small Business set-aside, with performance to be executed in St. Louis, Missouri. Meridian Medical Technologies is a wholly-owned subsidiary of Pfizer Inc. specializing in the development and...
- Meridian Medical Technologies, LLC, a Pfizer subsidiary specializing in medical countermeasures, was awarded a $992,655 delivery order by the Department of State's Bureau of Medical Services on September 30, 2024. This firm-fixed-price order, issued without set-aside designation, is for DuoDote autoinjectors—dual-agent devices containing atropine and pralidoxime chloride for treating nerve agent exposure. The delivery order is performance-based through September 29, 2025, with the place of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. The contract is for $3,262,840.74 to provide 4522513207 ANTIDOTE TREATMENT products. Meridian Medical Technologies is a manufacturer of pharmaceutical products and medical devices, including nerve agent antidote treatments and autoinjector kits. This contract does not have a set-aside designation. Meridian has a...
- This $17,955,751.55 firm fixed-price delivery order was awarded to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc., by the Department of State Bureau of Medical Services. The contract is for the provision of autoinjectors and associated training devices to be delivered globally to Department of State personnel through September 2028 under the Department's "MANDRAKE 3.0 IDIQ" contract. This single-award IDIQ contract vehicle has a total potential value of...
- This federal contract award is for the delivery of AUTOINJECTORS under Delivery Order Number Two, with a total ceiling value of $2,495,169.95. The prime contractor is Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. and a global provider of combination drug delivery solutions. The contracting agency is the Bureau of Medical Services, a civilian agency within the Department of Health and Human Services. This delivery order is not associated with any set-aside...
- The Defense Logistics Agency issued a $2,930.08 delivery order to AmerisourceBergen Drug Corp on March 18, 2026, for epinephrine 0.3 mg auto-injector supplies (2-pack). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical commodities to support military healthcare programs globally. Place of performance is Conshohocken, Pennsylvania. The order carries a firm...
- The Defense Logistics Agency issued a $24,977.52 delivery order to AmerisourceBergen Drug Corp on March 20, 2026, for epinephrine 0.3 mg auto-injectors with an ultimate completion date of March 23, 2026. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), valued at up to $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, Pennsylvania. The order...
- The Defense Logistics Agency issued a $7,747.48 delivery order to Amerisourcebergen Drug Corp on March 11, 2026, for epinephrine 0.15 mg auto-injector (two-pack units). The order is placed under the DLA Troop Support Medical IDC (SPE2DX), valued at up to $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, Pennsylvania. The order has a firm fixed price structure...
- The Defense Logistics Agency issued a $3,568.62 delivery order to Amerisourcebergen Drug Corp on March 26, 2026, for epinephrine 0.3 mg auto-injector (2-pack). This delivery order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical commodities to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order has a firm fixed price...
- The Defense Logistics Agency issued a $1,474.85 delivery order to Amerisourcebergen Drug Corp on March 17, 2026, for epinephrine 0.3 mg auto-injector (2-pack). The order was placed under the company's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026, which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, Pennsylvania. The ultimate...